Oceania Healthcare Ltd.NZX: OCA

OCA: Sales acceleration, cost reduction, and lower gearing drive improved financial performance

· Issued by Oceania Healthcare Ltd.

Underlying EBITDA rose 2.6% year-over-year, with strong cash inflow and reduced gearing to 37.5%. Focus is on accelerating sales, reducing unsold stock, and achieving NZD 5–7 million in cost savings for FY2026, while dividend resumption depends on sales and gearing.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.